Literature DB >> 23814094

Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies.

Bridget L Morse1, Marilyn E Morris.   

Abstract

γ-Hydroxybutyrate (GHB), a common drug of abuse, is often coingested with ethanol. Increasing renal clearance via monocarboxylate transporter (MCT) inhibition represents a potential therapeutic strategy in GHB overdose, as does inhibition of GABAB receptors. In this study, we investigate toxicokinetic/toxicodynamic interactions between GHB-ethanol and efficacy of treatment options for GHB-ethanol intoxication in rats. Sedation was assessed using the endpoint of return-to-righting reflex. Respiration was assessed using plethysmography. Coadministration of 2.0 g/kg ethanol i.v. with 600 mg/kg GHB i.v. increased sleep time compared with GHB alone. Administration of ethanol to steady-state concentrations of 0.1-0.2% and 0.3-0.4% (w/v) did not affect toxicokinetics of 600 mg/kg GHB i.v., or respiratory rate, but did result in significantly lower peak tidal volumes compared with GHB alone. Oral administration of 2.5 g/kg ethanol had no significant effect on toxicokinetics of 1500 mg/kg orally administered GHB. Pretreatment with specific receptor inhibitors indicated no effect of GABAA receptor inhibition on sleep time or respiratory depression in GHB-ethanol intoxication. GABAB receptor inhibition partially prevented sedation and completely prevented respiratory depression. Ethanol increased fatality when administered at 0.1-0.2% (4 of 10) and 0.3-0.4% (9 of 10) versus 1500 mg/kg GHB i.v. alone (0 of 10). Treatment with the MCT inhibitor, l-lactate, significantly decreased sleep time after GHB-ethanol and decreased fatality at 0.1-0.2% (0 of 10) and 0.3-0.4% ethanol (5 of 10). Treatment with a GABAB receptor antagonist completely prevented fatality at 0.3-0.4% (0 of 10). These data indicate that ethanol potentiates the sedative and respiratory depressant effects of GHB, increasing the risk of fatality. MCT and GABAB receptor inhibition represent potentially effective treatments in GHB-ethanol intoxication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23814094      PMCID: PMC3876779          DOI: 10.1124/jpet.113.206250

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

1.  Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.

Authors:  M A Carai; G Colombo; G Brunetti; S Melis; S Serra; G Vacca; S Mastinu; A M Pistuddi; C Solinas; G Cignarella; G Minardi; G L Gessa
Journal:  Eur J Pharmacol       Date:  2001-10-12       Impact factor: 4.432

2.  Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat.

Authors:  J T Lettieri; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

3.  Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes.

Authors:  S Liljequist; J Engel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients.

Authors:  Miguel Galicia; Santiago Nogue; Oscar Miró
Journal:  Emerg Med J       Date:  2011-06       Impact factor: 2.740

5.  Characterization of the pharmacokinetic and pharmacodynamic interaction between gamma-hydroxybutyrate and ethanol in the rat.

Authors:  Diederik K Van Sassenbroeck; Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Toxicol Sci       Date:  2003-04-15       Impact factor: 4.849

6.  Clinical course of gamma-hydroxybutyrate overdose.

Authors:  R L Chin; K A Sporer; B Cullison; J E Dyer; T D Wu
Journal:  Ann Emerg Med       Date:  1998-06       Impact factor: 5.721

7.  SGS742: the first GABA(B) receptor antagonist in clinical trials.

Authors:  Wolfgang Froestl; Michela Gallagher; Helen Jenkins; Annette Madrid; Thorsten Melcher; Sam Teichman; Cesare G Mondadori; Rodney Pearlman
Journal:  Biochem Pharmacol       Date:  2004-10-15       Impact factor: 5.858

8.  Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia.

Authors:  David G E Caldicott; Fiona Y Chow; Brian J Burns; Peter D Felgate; Roger W Byard
Journal:  Med J Aust       Date:  2004-09-20       Impact factor: 7.738

9.  Pharmacokinetics of 1,4-butanediol in rats: bioactivation to gamma-hydroxybutyric acid, interaction with ethanol, and oral bioavailability.

Authors:  Ho-Leung Fung; Pei-Suen Tsou; Jurgen B Bulitta; Doanh C Tran; Nathaniel A Page; David Soda; Sun Mi Fung
Journal:  AAPS J       Date:  2008-02-08       Impact factor: 4.009

10.  γ-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose.

Authors:  Bridget L Morse; Nisha Vijay; Marilyn E Morris
Journal:  Mol Pharmacol       Date:  2012-05-04       Impact factor: 4.436

View more
  9 in total

1.  Treatment of γ-Hydroxybutyric Acid and γ-Butyrolactone Overdose with Two Potent Monocarboxylate Transporter 1 Inhibitors, AZD3965 and AR-C155858.

Authors:  Kristin E Follman; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2019-04-22       Impact factor: 4.030

2.  A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.

Authors:  Nisha Vijay; Bridget L Morse; Marilyn E Morris
Journal:  Pharm Res       Date:  2014-12-06       Impact factor: 4.200

3.  Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

Review 4.  γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.

Authors:  Melanie A Felmlee; Bridget L Morse; Marilyn E Morris
Journal:  AAPS J       Date:  2021-01-08       Impact factor: 4.009

5.  γ-Hydroxybutyric Acid-Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 Inhibitors.

Authors:  Vivian Rodriguez-Cruz; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2021-05-07       Impact factor: 4.402

Review 6.  GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.

Authors:  Francesco P Busardò; Alan W Jones
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

Review 7.  Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.

Authors:  Enrico Marinelli; Renata Beck; Antonio Malvasi; Alfredo Fabrizio Lo Faro; Simona Zaami
Journal:  Arh Hig Rada Toksikol       Date:  2020-03-01       Impact factor: 1.948

8.  Toxicokinetic/Toxicodynamic Interaction Studies in Rats between the Drugs of Abuse γ-Hydroxybutyric Acid and Ketamine and Treatment Strategies for Overdose.

Authors:  Nisha V Kwatra; Marilyn E Morris
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

9.  Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid.

Authors:  Vivian Rodriguez-Cruz; Tianjing Ren; Marilyn E Morris
Journal:  Biopharm Drug Dispos       Date:  2021-07-08       Impact factor: 1.831

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.